文献速递心血管CT

冠状动脉斑块成分对有症状阻塞性冠心病患者的预后价值

Prognostic value of coronary plaque composition in symptomatic patients with obstructive coronary artery disease.
PubMed 文献 · Eur Radiol · 2025-01-24

该多中心注册研究纳入2009至2019年连续2312例有症状且CCTA至少一处≥50%狭窄的阻塞性冠心病患者,中位随访6.7年,319例(13.8%)发生MACE。在传统危险因素与CAD负荷模型基础上加入非钙化斑块段数,模型判别与重分类均改善(C统计量提升0.03,净重分类改善28.6%,综合判别指数5.4%,均P<0.001)。

要点

  • CCTA斑块成分分析可独立于传统危险因素和CAD负荷预测MACE。
  • 近端≥50%狭窄段数、阻塞性CAD血管数、非钙化斑块段数均与MACE独立相关(均P<0.001)。
  • 加入非钙化斑块段数后模型C统计量提升0.03、净重分类改善28.6%。

核心结论

  • 在有症状阻塞性冠心病患者中,CCTA斑块成分分析对MACE的预测具有超出传统危险因素与CAD负荷模型的增量预后价值。

研究设计与样本

  • 多中心注册研究,2009至2019年连续纳入有症状且CCTA至少一处≥50%狭窄的阻塞性CAD患者2312例(平均年龄70±12岁,46%为男性),中位随访6.7年(5.9-9.1),以心血管死亡或非致死性心肌梗死定义MACE。

关键影像表现/征象

  • 对每个冠状动脉节段肉眼评分狭窄程度与斑块成分,斑块分为非钙化、混合和钙化三类。
  • 非钙化斑块段数与MACE独立相关(P<0.001)。
  • 近端≥50%狭窄段数与阻塞性CAD血管数均与MACE独立相关(均P<0.001)。

诊断标准与关键数值

  • 模型1为临床传统危险因素;模型2为模型1加CAD负荷(近端≥50%狭窄段数加阻塞性CAD血管数);模型3为模型2加非钙化斑块段数。
  • 模型3判别与重分类改善最佳:C统计量提升0.03、净重分类改善28.6%、综合判别指数5.4%(均P<0.001)。
  • 阻塞性CAD定义为CCTA至少一处≥50%狭窄。

临床应用与阅片要点

  • 阅片时除报告狭窄程度与CAD负荷外,可对斑块成分(非钙化、混合、钙化)进行节段性评分并记录非钙化斑块段数。
  • 非钙化斑块段数可作为超出传统危险因素和CAD负荷的预后信息写入报告。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine whether plaque composition analysis defined by cardiac CT can provide incremental prognostic value above coronary artery disease (CAD) burden markers in symptomatic patients with obstructive CAD.

MATERIALS AND METHODS: Between 2009 and 2019, a multicentric registry included all consecutive symptomatic patients with obstructive CAD (at least one ≥ 50% stenosis on CCTA) and was followed for major adverse cardiovascular (MACE) defined by cardiovascular death or nonfatal myocardial infarction. Each coronary segment was scored visually for both the degree of stenosis and composition of plaque, which were classified as non-calcified, mixed, or calcified. To assess the prognostic value of each CCTA findings, different multivariable Cox regression models were used: model 1: clinical (traditional risk factors); model 2: model 1 + CAD burden (number of proximal segments with stenosis ≥ 50% + number of vessels with obstructive CAD); and model 3: model 2 + plaques feature (number of segments with non-calcified plaque).

RESULTS: Of 2312 patients (mean age 70 ± 12 years, 46% men), 319 experienced a MACE (13.8%) (median follow-up: 6.7 years (5.9-9.1)). The number of proximal segments with ≥ 50% stenosis, the number of vessels with obstructive CAD, and the number of segments with non-calcified plaque were all independently associated with MACEs (all p < 0.001). The addition of plaque composition analysis (model 3) showed the best improvement in model discrimination and reclassification (C-statistic improvement = 0.03; net reclassification improvement = 28.6%; integrative discrimination index = 5.4%, all p < 0.001).

CONCLUSIONS: In this population, the analysis of coronary plaque composition had an incremental prognostic value to predict MACEs above a model combining traditional risk factors and CAD burden.

KEY POINTS: Question Several coronary computed tomography angiography (CCTA) studies have shown the potential interest of plaque composition analysis, which can be further evaluated. Findings In symptomatic patients with obstructive coronary artery disease (CAD), plaque composition analysis had an incremental prognostic value above a model combining traditional risk factors and CAD burden. Clinical relevance In symptomatic patients with obstructive CAD, plaque composition analysis using CCTA has a strong incremental prognostic value above a model combining traditional risk factors and CAD burden, thus translating into a more accurate long-term major adverse cardiovascular event prediction.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Gall E, Pezel T, Toupin S, et al. Prognostic value of coronary plaque composition in symptomatic patients with obstructive coronary artery disease. Eur Radiol. 2025. PMID: 39853336. doi:10.1007/s00330-025-11353-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。